1. Home
  2. QLI

QLI

Qilian International Holding Group Ltd.

Logo Qilian International Holding Group Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.

Founded: N/A Country:
China
China
Employees: N/A City: N/A
Market Cap: 25.0M IPO Year: 2021
Target Price: N/A AVG Volume (30 days): 165.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.22 EPS Growth: N/A
52 Week Low/High: $0.35 - $1.30 Next Earning Date: 04-30-2024
Revenue: $46,471,478 Revenue Growth: -18.61%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: